Friedman, H. S., Yung, W. A., Jackson, E., Provenzale, J., Leeds, N., Conrad, C., … Dugan, M. (2001). A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel oral VEGF-R TK inhibitor in patients with recurrent GBM. CLINICAL CANCER RESEARCH, 7(11), 3665S-3665S.

Friedman, H. S., W. A. Yung, E. Jackson, J. Provenzale, N. Leeds, C. Conrad, A. Walker, A. Henry, D. Laurent, and M. Dugan. “A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel oral VEGF-R TK inhibitor in patients with recurrent GBM.” CLINICAL CANCER RESEARCH 7, no. 11 (November 1, 2001): 3665S-3665S.

Friedman HS, Yung WA, Jackson E, Provenzale J, Leeds N, Conrad C, et al. A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel oral VEGF-R TK inhibitor in patients with recurrent GBM. CLINICAL CANCER RESEARCH. 2001 Nov 1;7(11):3665S-3665S.

Friedman, H. S., et al. “A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel oral VEGF-R TK inhibitor in patients with recurrent GBM.” CLINICAL CANCER RESEARCH, vol. 7, no. 11, AMER ASSOC CANCER RESEARCH, Nov. 2001, pp. 3665S-3665S.

Friedman HS, Yung WA, Jackson E, Provenzale J, Leeds N, Conrad C, Walker A, Henry A, Laurent D, Dugan M. A phase I trial of PTK787/ZK 222584 (PTK/ZK), a novel oral VEGF-R TK inhibitor in patients with recurrent GBM. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2001 Nov 1;7(11):3665S-3665S.